Independent Testing

Quality Control

Identity, purity, potency, heavy metals, sterility, endotoxin, and a fentanyl screen. Verified by accredited third-party labs before any vial leaves our facility. Every result is published on the product’s Certificate of Analysis.

What we test for, and how.

Every method below runs on every product. Limits reflect our internal release specification — typically tighter than pharmacopeial minimums.

1RP-HPLC

Purity

Reverse-phase HPLC quantifies the target compound against impurities and process residuals, referenced to a certified standard.

Release limit
≥ 99.0%
Instrument
Agilent 1260 Infinity II
2Amino Acid Analysis

Content Verification

Acid hydrolysis followed by amino-acid quantification confirms mass and concentration match the labeled potency.

Release limit
Labeled potency confirmed
Instrument
Hitachi L-8900
3ESI / MALDI-MS

Identity Confirmation

Mass spectrometry confirms the exact molecular weight and flags any truncated or modified sequences.

Release limit
± 0.1 Da of theoretical
Instrument
Thermo Q Exactive
4ICP-MS

Heavy Metals Screening

Inductively-coupled plasma mass spectrometry screens for lead, arsenic, cadmium, and mercury below USP <232> thresholds.

Release limit
USP <232> limits
Instrument
Agilent 7900 ICP-MS
5USP <71>

Sterility Testing

Membrane filtration into fluid thioglycollate and tryptic soy broth, incubated and inspected per USP <71>.

Release limit
No growth at 14 days
Instrument
Membrane filtration
6LAL Kinetic Chromogenic

Endotoxin Testing

Limulus amebocyte lysate assay quantifies bacterial endotoxin for cell-culture compatibility.

Release limit
< 0.5 EU/mg
Instrument
Charles River Endosafe
7LC-MS/MS

Fentanyl Screen

Targeted LC-MS/MS screen confirms the absence of fentanyl and fentanyl-analog contamination on every product.

Release limit
Not detected
Instrument
Thermo TSQ Altis
8Independent Release Review

Conformity Verification

A final third-party review confirms every assay result matches the product's release specification and that the published COA is true to the vial.

Release limit
Matches release spec & COA
Instrument
ISO/IEC 17025 lab review

From synthesis to shelf, every sample is tracked.

Every product is tracked from the point of synthesis through purification, lyophilization, fill, and every test point, and its results are published on the Certificate of Analysis.

  1. 1

    Synthesis complete

    Solid-phase peptide synthesis, sequence assembled step by step.

  2. 2

    RP-HPLC purification

    Pooled fractions confirmed to ≥ 99% before moving forward.

  3. 3

    Lyophilization

    Freeze-dried to powder; residual moisture measured and logged.

  4. 4

    Third-party release panel

    All eight independent assays run and passed before release.

  5. 5

    Fill & seal

    Vialed under an argon-purged headspace and sealed.

  6. 6

    COA published

    Certificate of Analysis posted to the product page before shipping.

Common questions about our testing

Independent laboratories accredited to ISO/IEC 17025 run the identity, purity, and contamination assays. Our internal QC repeats HPLC on every product as an additional release gate.

Before the product is released to fulfillment. If a product has no Certificate of Analysis on its product page, it cannot ship.

It is quarantined and destroyed. We never downgrade, re-sell, or sub-brand failed material.

Yes — every published COA links to the full HPLC trace and mass spectrum as downloadable PDFs.

Ascend Science GLP-2 TZ research vialAscend Science GLP-3 RT research vial

All the research compounds you need, with the confidence that every product is 8× tested before it ships.

Subscribe to our Newsletter

Subscribe to our newsletter to get daily insights, news, updates.